150 mg Fosaprepitant Dimeglumine For Injection is a medication used in the prevention of chemotherapy-induced nausea and vomiting (CINV). Chemotherapy can cause the release of certain substances in the body, such as substance P, which triggers nausea and vomiting. This is often used in combination with other antiemetic medications to provide comprehensive control of CINV and improve the overall quality of life for patients undergoing chemotherapy. Fosaprepitant is converted into aprepitant in the body, and aprepitant blocks the action of substance P, effectively preventing and controlling CINV. 150 mg Fosaprepitant Dimeglumine For Injection helps prevent both acute and delayed nausea and vomiting associated with certain chemotherapy regimens.
Form - Liquid